MARKET

PRNAF

PRNAF

Alterity Therapeutics Ltd
OTCPK
0.0036
NaN%
Closed 09:30 03/24 EDT
OPEN
--
PREV CLOSE
0.0036
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0036
52 WEEK LOW
0.0036
MARKET CAP
23.96M
P/E (TTM)
-1.4400
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PRNAF last week (0317-0321)?
Weekly Report · 14h ago
Weekly Report: what happened at PRNAF last week (0310-0314)?
Weekly Report · 03/17 11:00
Weekly Report: what happened at PRNAF last week (0303-0307)?
Weekly Report · 03/10 11:02
Alterity Therapeutics Reports Progress Amid Financial Losses
TipRanks · 03/10 03:51
Weekly Report: what happened at PRNAF last week (0224-0228)?
Weekly Report · 03/03 11:01
Buy Rating for Alterity Therapeutics: Strong Financial Position and Promising Clinical Results
TipRanks · 03/01 19:05
Alterity Therapeutics Announces Extraordinary General Meeting for Share Issuance Resolutions
TipRanks · 02/28 04:48
Alterity Therapeutics Reports Increased Losses Amid Revenue Decline
TipRanks · 02/28 04:28
More
About PRNAF
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.

Webull offers Alterity Therapeutics Ltd stock information, including OTCPK: PRNAF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRNAF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRNAF stock methods without spending real money on the virtual paper trading platform.